Dr. Adeline Vanderver

Dr. Adeline Vanderver, M.D. is a Professor of Neurology in the Division of Neurology at the Children’s Hospital of Philadelphia (CHOP), the Department of Neurology at the Perelman School of Medicine, University of Pennsylvania and the Jacob A. Kamens Endowed Chair in Neurologic Disorders and Translational Neurotherapeutics. She is also Program Director of the Leukodystrophy Center of Excellence at CHOP. Dr. Vanderver graduated with a degree in medicine from Universite Catholique de Louvain in Brussels, Belgium. She completed her residency in pediatrics at Nemours/A.I. duPont Hospital for Children in Wilmington, DE, and Thomas Jefferson University in Philadelphia, PA. She then pursued a child neurology fellowship at Children's National Medical Center in Washington, DC, and a fellowship in biochemical genetics at the National Human Genome Research Institute/National Institutes of Health in Bethesda, MD.

Under Dr. Vanderver’s leadership, the multidisciplinary Leukodystrophy Center team is focused on creating new standards of care for children with leukodystrophies by advancing leukodystrophy gene discovery, creating new therapies, and supporting and advocating for patients and their families. In parallel with this strong clinical program, Dr. Vanderver’s preclinical and clinical research projects will aim to discover molecular therapeutics that target the genetics of leukodystrophy subtypes.  In addition to her clinical and research efforts, Dr. Vanderver leads the Global Leukodystrophy Initiative, an NIH funded consortium that includes parents, clinicians and researchers, to raise disease awareness, create clinical trial readiness, and explore natural history of the leukodystrophies.